Clinical Trial: Testing Two Doses of Nebulized Ketamine for Postoperative Sore Throat

U.S., Aug. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07746115) titled 'Testing Two Doses of Nebulized Ketamine for Postoperative Sore Throat' on July 30.

Brief Summary: Postoperative sore throat (POST) is one of the most common complications following general anesthesia with endotracheal intubation, affecting patient comfort, delaying recovery, and reducing overall satisfaction with perioperative care. Although POST is usually self-limiting, its high incidence makes it an important target for preventive interventions.

Nebulized ketamine has emerged as a promising non-invasive strategy for reducing POST because of its local analgesic and anti-inflammatory effects mediated through N-methyl-D-aspartate (N...